• Air Traffic Control
  • Annual Highway Report
  • Open Enrollment
  • Events
  • Reason facebook
  • Reason twitter
  • Reason youtube
Reason Foundation
  • About
    • About Us
    • Contact Us
    • Email Newsletters
    • Events
    • FAQs
    • Jobs & Internships
    • Savas Award
    • Shop
    • Staff
    • Trustees & Officers
  • Experts

      Browse Our Experts

      • Aaron Smith
        Director of Education Reform
      • Adrian Moore
        Vice President, Policy
      • Baruch Feigenbaum
        Senior Managing Director, Transportation Policy
      • Geoff Lawrence
        Research Director
      • Guy Bentley
        Director of Consumer Freedom
      • Leonard Gilroy
        Vice President, Government Reform
      • Robert Poole
        Director of Transportation Policy
      • Vittorio Nastasi
        Director of Criminal Justice Policy
      • View All Experts
  • Topics

      Browse Our Topics

      • Air Traffic Control
      • Annual Highway Report
      • Consumer Freedom
      • Criminal Justice Reform
      • Drug Policy
      • Education
      • Gov’t Financial Transparency
      • Pension Reform
      • Technology
      • Transportation
      • Urban Growth and Land Use
      • View All Topics
  • Publications
    • Latest
    • Annual Highway Report
    • Annual Pension Report
    • Annual Privatization Report
    • Aviation Newsletter
    • Backgrounders
    • Commentaries
    • Data Visualization
    • Education Newsletter
    • Email Newsletters
    • Government Financial Project
    • Pension Reform Newsletter
    • Policy Studies
    • Psychedelics Newsletter
    • Public Schools Without Boundaries
    • Testimony
    • Transportation Newsletter
    • Amicus Briefs
  • Reason.com
  • Donate
    • Donate Online
    • Donate Crypto
    • Ways To Give
    • Torchbearer Society
    • Planned Giving

Topics › Drug Policy › Ibogaine

Ibogaine


Ibogaine treatment for opioid use disorder

Ibogaine treatment for opioid use disorder

By Madison Carlino

A new Reason Foundation brief reviews the reported results of studies investigating the potential of ibogaine in treating opioid addiction.

Ibogaine offers major promise in treating addiction, mental health
Ibogaine offers major promise in treating addiction, mental health

By Madison Carlino and Leonard Gilroy

Ibogaine offers breakthrough treatment for mental health, addiction, and TBIs
Ibogaine offers breakthrough treatment for mental health, addiction, and TBIs

By Aubri Strachan

Federal agencies’ next moves to accelerate the availability of psychedelic therapies 
Federal agencies’ next moves to accelerate the availability of psychedelic therapies 

By Geoffrey Lawrence

Ibogaine and veterans’ mental health
Ibogaine and veterans’ mental health

By Aubri Strachan

  • How Trump’s executive order could accelerate widespread access to psychedelic therapies
    How Trump’s executive order could accelerate widespread access to psychedelic therapies

    Commentary by Leonard Gilroy and Geoffrey Lawrence

  • Mississippi and West Virginia to join Texas ibogaine initiative 
    Mississippi and West Virginia to join Texas ibogaine initiative 

    Commentary by Geoffrey Lawrence

  • State psychedelics legalization and policy roundup — March 2026
    State psychedelics legalization and policy roundup — March 2026

    Commentary by Gregory Ferenstein

  • Psychedelics Policy Newsletter: New real-world psilocybin study, ibogaine educational materials, and more
    Psychedelics Policy Newsletter: New real-world psilocybin study, ibogaine educational materials, and more

    Psychedelics Policy Newsletter by Gregory Ferenstein

  • State psychedelics legalization and policy roundup — December 2025
    State psychedelics legalization and policy roundup — December 2025

    Commentary by Gregory Ferenstein

  • Proposed Model Policy: “Veterans Mental Health Innovations Act” 
    Proposed Model Policy: “Veterans Mental Health Innovations Act” 

    Backgrounder by Kaitlyn Boecker, Geoffrey Lawrence and Leonard Gilroy

  • Model legislation would authorize groundbreaking research into ibogaine for mental health
    Model legislation would authorize groundbreaking research into ibogaine for mental health

    Backgrounder by Kaitlyn Boecker, Geoffrey Lawrence and Leonard Gilroy

  • Ibogaine could transform public spending on opioid treatment
    Ibogaine could transform public spending on opioid treatment

    Backgrounder by Madison Carlino

  • FAQ: Timeline for FDA ibogaine approval
    FAQ: Timeline for FDA ibogaine approval

    FAQ by Gregory Ferenstein

Ibogaine Policy Studies

  • FAQ: Timeline for FDA ibogaine approval
    FAQ: Timeline for FDA ibogaine approval

    FAQ by Gregory Ferenstein

  • Ibogaine treatment for opioid use disorder
    Ibogaine treatment for opioid use disorder

    Policy Brief by Madison Carlino

  • A policy framework for personal psychedelics licenses
    A policy framework for personal psychedelics licenses

    Policy Brief by Gregory Ferenstein

More Ibogaine

  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next

Follow

  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • RSS

Email Updates

Get weekly updates from Reason.

This field is for validation purposes and should be left unchanged.

More About Reason Foundation

  • About
  • Contact
  • Donate
  • Email Newsletters
  • Events
  • Jobs and Internships
  • Policy Research
  • Reason magazine
  • Shop

Contact

Reason Foundation
5737 Mesmer Ave.
Los Angeles, CA 90230
(310) 391-2245

1630 Connecticut Ave NW
Suite 600
Washington, DC 20009
(202) 986-0916

Privacy Policy
Accessibility

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 
 
Copyright © 2026 Reason Foundation